Skip to product information
1 of 1

ANGELINI (A.C.R.A.F.) SpA

Verolax 3 g 6 single dose rectal solution

Verolax 3 g 6 single dose rectal solution

Regular price €5,60
Regular price €5,60 Sale price €5,60
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

Verolax 3 g 6 single-dose rectal solution is a glycerin-based laxative indicated for occasional and stubborn constipation . The single-dose micro-enema acts locally with rapid action , softening the stool and stimulating evacuation. Enriched with mallow and chamomile , it is gentle on the rectal mucosa. Practical, hygienic, and ready to use , it is ideal for children and adults for targeted intestinal well-being .

NET WEIGHT OF THE PRODUCT

EAN

026525042

MINSAN

026525042

View full details

Verolax 3 g 6 single-dose rectal solution is a glycerin-based laxative , specifically formulated for the rapid treatment of occasional and obstinate constipation . Each pack contains 6 single-dose containers of 3 g of rectal solution, ideal for practical and hygienic use. The product acts locally in the rectum, promoting natural evacuation without being absorbed by the body, making it particularly suitable for those who need a targeted and short-term treatment against constipation. Glycerin , the active ingredient of Verolax, exerts an osmotic action that draws water into the intestine, softening the stool and gently stimulating intestinal peristalsis. The presence of fluid extracts of mallow and chamomile helps to soothe and protect the rectal mucosa, while wheat starch and purified water complete the formulation, ensuring an effective and well-tolerated action even in the most sensitive subjects. Verolax 3 g single-dose rectal solution is particularly suitable for children and for those looking for a practical and safe single-dose enema , thanks to the ready-to-use format that reduces the risk of contamination and facilitates administration. The product is an easily available over-the-counter drug , produced by Angelini, a leading company in the pharmaceutical sector. Choosing Verolax means relying on a fast-acting microenema , ideal for solving constipation problems and promoting intestinal well-being in a safe, delicate and immediate way. Perfect for those who want an effective treatment of constipation without resorting to systemic solutions, Verolax 3 g 6 single-dose rectal solution represents the optimal choice for daily intestinal well-being .


ACTIVE INGREDIENTS

Active ingredients contained in Verolax 3 g 6 single-dose rectal solution - What is the active ingredient of Verolax 3 g 6 single-dose rectal solution?

Verolax “6.75 g Adults Rectal Solution” 6 Single-Dose Containers 9 G : Each 9 G single-dose container contains: Active ingredient : glycerin 6.75 g Verolax “2.25 g Children Rectal Solution” 6 Single-Dose Containers 3 G : Each 3 G single-dose container contains: Active ingredient: glycerin 2.25 g Verolax “2.25 g Adults Suppositories” 18 Suppositories : Each adult suppository contains: Active ingredient : glycerin 2.25 g Verolax “1.375 g Children Suppositories” 18 Suppositories : Each children's suppository contains: Active ingredient : glycerin 1.375 g Verolax “0.675 g Infants Suppositories” 12 Suppositories : Each infant ... 0.675

EXCIPIENTS

Composition of Verolax 3 g 6 single-dose rectal solution - What does Verolax 3 g 6 single-dose rectal solution contain?

Rectal solution Adults and Children: Mallow fluid extract; Chamomile fluid extract; Wheat starch; Purified water. Suppositories Adults, Children, Infants: Sodium stearate, Sodium carbonate.

DIRECTIONS

Therapeutic indications Verolax 3 g 6 single-dose rectal solution - Why is Verolax 3 g 6 single-dose rectal solution used? What is it used for?

Constipation.

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Verolax 3 g 6 single-dose rectal solution - When should Verolax 3 g 6 single-dose rectal solution not be used?

Known individual hypersensitivity to the product. Anorectal affections, hemorrhagic rectocolitis and inflammation of hemorrhoids.

DOSAGE

Quantity and method of taking Verolax 3 g 6 single-dose rectal solution - How do you take Verolax 3 g 6 single-dose rectal solution?

Rectal solution: 1 or 2 single-dose containers in 24 hours. In case of obstinate constipation, no more than 2 doses can be introduced into the rectum at the same time. Suppositories: 1 suppository as needed. Do not exceed the recommended doses.

CONSERVATION

Storage Verolax 3 g 6 single-dose rectal solution - How is Verolax 3 g 6 single-dose rectal solution stored?

No special storage precautions.

WARNINGS

Warnings Verolax 3 g 6 single-dose rectal solution - About Verolax 3 g 6 single-dose rectal solution it is important to know that:

Continuous use of laxatives can cause addiction or harm of various kinds. Do not use laxatives if you have abdominal pain, nausea and vomiting. If constipation is persistent, consult your doctor.

INTERACTIONS

Interactions Verolax 3 g 6 single-dose rectal solution - Which medicines or foods can modify the effect of Verolax 3 g 6 single-dose rectal solution?

No interactions with other drugs have been found.

SIDE EFFECTS

Like all medicines, Verolax 3 g 6 monodose rectal solution can cause side effects - What are the side effects of Verolax 3 g 6 monodose rectal solution?

The only effects that may be encountered are of an irritative nature, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.

OVERDOSE

Overdose Verolax 3 g 6 single-dose rectal solution - What are the risks of Verolax 3 g 6 single-dose rectal solution in case of overdose?

There are no known symptoms of overdose.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Verolax 3 g 6 single-dose rectal solution.

Based on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.

DRIVING AND USE OF MACHINERY

Take Verolax 3 g 6 single-dose rectal solution before driving or using machinery - Does Verolax 3 g 6 single-dose rectal solution affect driving or using machinery?

Taking the drug does not alter the ability to drive or use machines.
1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.